Why read this report if you work in biopharma?
Discover where microgravity could solve real pharmaceutical R&D challenges, from biologics formulation to advanced tissue models, and how these opportunities can be tested through a low-risk, industry-led approach.
- This report starts with pharmaceutical R&D challenges, not space technology. It identifies where microgravity may offer a genuine advantage and, equally importantly, where it may not.
- It explores near-term opportunities ranging from biologics formulation and manufacturing through to tissue engineering, organoids and advanced biological models.
- It sets out a practical, low-risk route to test these opportunities, protecting commercially sensitive information through confidential engagement and staged decision gates before major investment is required.
Download the report
|
